Semnur Pharmaceuticals
Why Robinhood?
You can watch SMNR and buy or sell other stocks, ETFs, and their options commission-free!About SMNR
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate, SP-102, is a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain.
SMNR Key Statistics
Stock Snapshot
Semnur Pharmaceuticals(SMNR) stock is priced at $8.00, giving the company a market capitalization of 1.84B. It carries a P/E multiple of -8.12.
On 2026-03-11, Semnur Pharmaceuticals(SMNR) stock moved within a range of $7.92 to $8.00. With shares now at $8.00, the stock is trading +1.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 99, compared to an average daily volume of 10.3.
The stock's 52-week range extends from a low of $4.50 to a high of $23.00.
The stock's 52-week range extends from a low of $4.50 to a high of $23.00.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.